Skip to main content

Table 2 DU90% in Queensland and in Australia for the overall NSAID utilization in Concession beneficiaries between 1997 and 2003

From: Non-steroidal anti-inflammatory drugs, Cyclooxygenase-2 inhibitors and paracetamol use in Queensland and in the whole of Australia

Australia DU90%

1997–1999%

2000%

2001%

2002%

2003%

Naproxen* 28

Celecoxib+ 35

Celecoxib+ 40

Celecoxib+ 39

Celecoxib+ 35

Diclofenac** 21

Naproxen* 20

Rofecoxib+ 16

Rofecoxib+ 22

Rofecoxib+ 25

Ketoprofen# 16

Diclofenac** 15

Naproxen* 16

Naproxen* 12

Diclofenac** 12

Piroxicam# 10

Ketoprofen# 9

Diclofenac** 14

Diclofenac** 12

Naproxen* 11

Indomethacin* 7

Piroxicam# 7

Ketoprofen# 7

Ketoprofen# 5

Meloxicam+ 9

Ibuprofen** 6

Ibuprofen** 5

   

Queensland DU 90%

1997–1999%

2000%

2001%

2002%

2003%

Naproxen* 27

Celecoxib+ 45

Celecoxib+ 43

Celecoxib+ 40

Celecoxib+ 35

Diclofenac** 20

Naproxen* 14

Rofecoxib+ 16

Rofecoxib+ 22

Rofecoxib+ 26

Ketoprofen# 17

Diclofenac** 13

Naproxen* 10

Diclofenac** 9

Diclofenac** 9

Piroxicam# 12

Ketoprofen# 8

Diclofenac** 10

Naproxen* 9

Meloxicam+ 8

Ibuprofen** 9

 

Ketoprofen# 5

Ibuprofen** 5

Naproxen* 8

Indomethacin* 5

 

Ibuprofen** 5

Ketoprofen# 4

Ibuprofen** 5

+ Cox-2 inhibitors

** ns-NSAIDs low risk

# ns-NSAIDs high risk

* ns-NSAIDs moderate risk